Organizers: IRB Barcelona
Date: Friday 03 May, 12.00h
Place: Auditori PCB, Parc Cientific de Barcelona
Plenary Seminar
Organizers: IRB Barcelona
Date: Friday 03 May, 12.00h
Place: Auditori PCB, Parc Cientific de Barcelona
Plenary Seminar
How to results from your bench reach the market? Innovation Department will give an overview about the innovation process and tech transfer applied to your research activities at IRB Barcelona.
Key points addressed during the talk:
Organizers: IRB Barcelona
Date: Friday 10 May, 12.00h
Place: Felix Serratosa, Parc Cientific de Barcelona
Host: Fran Supek, PhD - IRB Barcelona
Abstract
Organizers: IRB Barcelona
Date: Friday 24 May, 12.00h
Place: Félix Serratosa, Parc Cientific de Barcelona
Plenary Seminar
The Barcelona Institute of Science and Technology (BIST) and its participating centers are pleased to announce the organization of "From Science to Business", a week-long hands-on workshop with 4-day on-site sessions on entrepreneurship in research, delivered in collaboration with ESADE Business School.
From Science to Business will allow participants to:
Organizers: IRB Barcelona
Date: Friday 31 May, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona
Host: Ángel R. Nebreda, PhD - IRB Barcelona
Abstract
Organizers: IRB Barcelona
Date: Friday 14 June, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona
Host: Cayetano González, PhD - IRB Barcelona
Abstract
Date: 13-15 November 2019
Place: Van der Valk hotel, Nijmegen (Netherlands)
Early bird registration period: April 1 – June 30, 2019
Notification of travel grants awardees: July 31, 2019
Late registration period: July 1 – September 16, 2019
Notification of abstract selection: October 2019
Register here:
http://enablenetwork.eu/registration/
Stimulation of the immune system by blocking immunosuppressive checkpoints has shown spectacular impact in cancer therapy. There is increasing evidence that immunotherapy might elicit similar outcomes in non-oncological settings. This is the case, for example, of neurodegenerative disorders where blockade of immune checkpoints has beneficial effects. More generally, aging is associated with a progressive unbalance in the composition and activity of the different components of the immune system.